The present study supports this hypothesis, as ANGPTL2 deficiency reduced inflammation across multiple organs and attenuated obesity‐induced cardiac dysfunction, kidney fibrosis, and adipocyte hypertrophy. The gene discussed is ANGPTL2; the disease is obesity disorder.